Compositions and methods for sequencing multiple regions of a template molecule using enzyme-based reagents

Abstract

The present disclosure provides compositions comprising enzyme-based reagents, and methods using the enzyme-based reagents, for nucleic acid sequencing. The enzyme-based reagents efficiently remove sequencing read products from a first sequenced region of a template molecule, thereby reducing residual signals in a second sequenced region on the same template molecule.

Description

Translation 61546 Title: Compositions and Methods for Sequencing Multiple Regions of a Template Molecule Using Enzyme-Based Reagents Abstract: This invention discloses compositions comprising enzyme-based reagents and methods for nucleic acid sequencing using said enzyme-based reagents. Enzyme-based reagents can effectively remove sequencing reads from the first sequencing region of a template molecule, thereby reducing residual signal in a second sequencing region on the same template molecule.

Claims

WHAT IS CLAIMED IS:

1. A method for sequencing a nucleic acid template molecule, comprising: a) providing at least one single-stranded nucleic acid template molecule immobilized to a support wherein the at least one single-stranded nucleic acid template molecule is covalently attached or hybridized to a capture primer which is immobilized to the support; b) hybridizing at least one first sequencing primer to a first region of the nucleic acid template molecule and conducting one or more cycles of sequencing reactions thereby generating at least one first extension duplex each comprising a first sequencing read product hybridized to the template molecule; and c) contacting the first extension duplex with a double-stranded DNA specific enzyme having 5’ to 3’ exonuclease activity under a condition suitable to degrade the first sequencing read product and retain the template molecule thereby removing at least a portion of the first sequencing read product from the first region of the template molecule; and d) washing the retained template molecule at a temperature of 22-27 °C to remove the double-stranded DNA specific enzyme having 5’ to 3’ exonuclease activity.

2. The method of claim 1, further comprising: e) hybridizing at least one second sequencing primer to a second region of the same nucleic acid template molecule and conducting one or more sequencing reactions thereby generating a second extension duplex comprising a second sequencing read product hybridized to the template molecule; f) contacting the second extension duplex with a double-stranded DNA specific enzyme having 5’ to 3’ exonuclease activity under a condition suitable to degrade the second sequencing read product and retain the template molecule thereby removing at least a portion of the second sequencing read product from the second region of the template molecule; andg) washing the retained template molecule at a temperature of 22-27 °C to remove the double-stranded DNA specific enzyme having 5’ to 3’ exonuclease activity.

3. The method of claim 2, further comprising: h) hybridizing at least one third sequencing primer to a third region of the same nucleic acid template molecule and conducting one or more sequencing reactions thereby generating a third extension duplex comprising a third sequencing read product hybridized to the template molecule; i) contacting the third extension duplex with a double-stranded DNA specific enzyme having 5’ to 3’ exonuclease activity under a condition suitable to degrade the third sequencing read product and retain the template molecule thereby removing at least a portion of the third sequencing read product from the third region of the template molecule; and j) washing the retained template molecule at a temperature of 22-27 °C to remove the double-stranded DNA specific enzyme having 5’ to 3’ exonuclease activity.

4. The method of claim 3, further comprising; repeating steps (h), (i) and (j) using a fourth sequencing primer that hybridizes to a fourth region of the same nucleic acid template molecule.

5. The method of claim 4, further comprising repeating steps (h), (i) and (j) using:(i) a fifth sequencing primer that hybridizes to a fifth region of the same nucleic acid template molecule;(ii) a sixth sequencing primer that hybridizes to a sixth region of the same nucleic acid template molecule;(iii) a seventh sequencing primer that hybridizes to a seventh region of the same nucleic acid template molecule;(iv) an eighth sequencing primer that hybridizes to an eighth region of the same nucleic acid template molecule;(v) a ninth sequencing primer that hybridizes to a ninth region of the same nucleic acid template molecule; and / or(vi) a tenth or more sequencing primer that hybridizes to a tenth or more region of the same nucleic acid template molecule.

6. The method of any one of claims 1-5, wherein conducting one or more sequencing reactions comprises conducting one or more sequencing cycle reactions.

7. The method of any one of claims 1-6, wherein the double-stranded DNA specific enzyme having 5’ to 3’ exonuclease activity comprises a T7 exonuclease enzyme.

8. The method of claim 7, wherein the T7 exonuclease enzyme is encoded by T7 phage gene 6.

9. The method of any one of claims 1-8, wherein the at least one single-stranded nucleic acid template molecule comprises one copy of the sequence-of-interest.

10. The method of claim 9, wherein the at least one single-stranded nucleic acid template molecule comprising one copy of the sequence-of-interest is generated via bridge amplification.

11. The method of any one of claims 1-10, wherein the at least one single-stranded nucleic acid template molecule comprises two or more tandem copies of the sequence-of- interest.

12. The method of claim 11, wherein the at least one single-stranded nucleic acid template molecule comprises two or more tandem copies of the sequence-of-interest is generated via rolling circle amplification.

13. The method of any one of claims 1-12, wherein the at least one single-stranded nucleic acid template molecule comprises at least one uridine nucleotide.

14. The method of any one of claims 1-12, wherein the at least one single-stranded nucleic acid template molecule lacks a uridine nucleotide.

15. The method of any one of the claims 1-14, wherein the single-stranded nucleic acid template molecule comprises at least one sequence-of-interest and at least one universal adaptor sequence.

16. The method of claim 15, wherein the at least one universal adaptor sequence is selected from:• a first surface primer binding site (or a complementary sequence thereof) which can hybridize to at least a portion of an immobilized first surface primer;• a second surface primer binding site (or a complementary sequence thereof) which can hybridize to at least a portion of an immobilized second surface primer;• a first sequencing primer site (or a complementary sequence thereof) which can hybridize to at least a portion of a forward sequencing primer;• a second sequencing primer site (or a complementary sequence thereof) which can hybridize to at least a portion of a reverse sequencing primer;• a first amplification primer binding site (or a complementary sequence thereof) which can hybridize to at least a portion of a forward amplification primer;• a second amplification primer binding site (or a complementary sequence thereof) which can hybridize to at least a portion of a reverse amplification primer;• a first sample index sequence;• a second sample index sequence;• a first compaction oligonucleotide binding site (or a complementary sequence thereof) which can hybridize to at least a portion of a first compaction oligonucleotide;• a second compaction oligonucleotide binding site (or a complementary sequence thereof) which can hybridize to at least a portion of a second compaction oligonucleotide;• a first unique molecular tag sequence; and / or• a second unique molecular tag sequence.

17. The method of claim 15 or 16, wherein the single-stranded nucleic acid template molecule comprises any combination of two or more universal adaptor sequences.

18. The method of claim 1, wherein the first sequencing read product of step b) comprises the first sequencing primer joined to a first polynucleotide generated by a polymerase- catalyzed primer extension reaction, wherein the first polynucleotide comprises a sequence complementary to at least a portion of the at least one single-stranded nucleic acid template molecule.

19. The method of claim 2, wherein the second sequencing read product of step e) comprises the second sequencing primer joined to a second polynucleotide generated by a polymerase-catalyzed primer extension reaction, wherein the second polynucleotide comprises a sequence complementary to at least a portion of the at least one singlestranded nucleic acid template molecule.

20. The method of claim 3, wherein the third sequencing read product of step h) comprises the third sequencing primer joined to a third polynucleotide generated by a polymerase- catalyzed primer extension reaction, wherein the third polynucleotide comprises a sequence complementary to at least a portion of the at least one single-stranded nucleic acid template molecule.

21. The method of claim 16 or 17, wherein the order of the sequencing the at least one single-stranded nucleic acid template molecule comprises: a) sequencing the sequence-of-interest; and b) sequencing the first sample index after sequencing the sequence-of-interest.

22. The method of claim 16 or 17, wherein the order of the sequencing the at least one single-stranded nucleic acid template molecule comprises: a) sequencing only a portion of the sequence-of-interest; b) sequencing the first sample index after sequencing the sequence-of-interest; and c) sequencing the full length of the sequence-of-interest after sequencing the first sample index.

23. The method of claim 16 or 17, wherein the order of the sequencing the at least one single-stranded nucleic acid template molecule comprises: a) sequencing the sequence-of-interest; b) sequencing the first sample index after sequencing the sequence-of-interest; and c) sequencing the second sample index after sequencing the first sample index.

24. The method of claim 16 or 17, wherein the order of the sequencing the at least one single-stranded nucleic acid template molecule comprises: a) sequencing only a portion of the sequence-of-interest; b) sequencing the first sample index after sequencing the sequence-of-interest; c) sequencing the second sample index after sequencing the first sample index; and d) sequencing the full length of the sequence-of-interest after sequencing the second sample index.

25. The method of claim 16 or 17, wherein the order of the sequencing the at least one single-stranded nucleic acid template molecule comprises: a) sequencing the first sample index; and b) sequencing the sequence-of-interest after sequencing the first sample index.

26. The method of claim 16 or 17, wherein the order of the sequencing the at least one single-stranded nucleic acid template molecule comprises: a) sequencing the first sample index; and b) sequencing only a portion of the sequence-of-interest after sequencing the first sample index.

27. The method of claim 16 or 17, wherein the order of the sequencing the at least one single-stranded nucleic acid template molecule comprises: a) sequencing the first sample index; b) sequencing the second sample index after sequencing the first sample index; and c) sequencing the sequence-of-interest after sequencing the second sample index.

28. The method of claim 16 or 17, wherein the order of the sequencing the at least one single-stranded nucleic acid template molecule comprises: a) sequencing the first sample index; b) sequencing the second sample index after sequencing the first sample index; and c) sequencing only a portion of the sequence-of-interest after sequencing the second sample index.

29. The method of claim 16 or 17, wherein the order of the sequencing the at least one single-stranded nucleic acid template molecule comprises: a) sequencing the first sample index; b) sequencing the sequence-of-interest after sequencing the first sample index; and c) sequencing the second sample index after sequencing the sequence-of-interest.

30. The method of claim 16 or 17, wherein the order of the sequencing the at least one single-stranded nucleic acid template molecule comprises: a) sequencing the first sample index; b) sequencing only a portion of the sequence-of-interest after sequencing the first sample index; and c) sequencing the second sample index after sequencing the sequence-of-interest.

31. The method of claim 16 or 17, wherein the order of the sequencing the at least one single-stranded nucleic acid template molecule comprises: a) sequencing the first sample index; b) sequencing only a portion of the sequence-of-interest after sequencing the first sample index; c) sequencing the second sample index after sequencing the sequence-of-interest; and d) sequencing the full length of the sequence-of-interest after sequencing the second sample index.

32. The method of any one of claims 1-31, wherein the conducting one or more sequencing reactions comprises conducting one or more cycles of a sequencing reaction with a sequencing polymerase and detectably labeled nucleotide analogs.

33. The method of claim 32, wherein the detectably labeled nucleotide analogs comprise nucleotides each comprise an aromatic nucleo-base, a five carbon sugar moiety, 1-10 phosphate groups, and a fluorophore.

34. The method of claim 32, wherein the detectably labeled nucleotide analogs comprise nucleotides each comprising an aromatic nucleo-base, a five carbon sugar moiety having a removable chain terminating group at the 3' carbon sugar position, 1-10 phosphate groups, and a fluorophore.

35. The method of claim 34, wherein the removable chain terminating group of the 3’ carbon sugar position comprises an alkyl group, alkenyl group, alkynyl group, allyl group, aryl group, benzyl group, azide group, azido group, O-azidomethyl group, amine group, amide group, keto group, isocyanate group, phosphate group, thio group, disulfide group, carbonate group, urea group, or silyl group, and wherein the removable chain terminating moiety is cleavable with a chemical compound to generate an extendible 3' OH moiety on the sugar group.

36. The method of claim 32, wherein the plurality of detectably labeled nucleotide analogs comprise one type of nucleotide selected from the group consisting of dATP, dGTP, dCTP, dTTP and dUTP.

37. The method of claim 32, wherein the plurality of detectably labeled nucleotide analogs comprise a mixture of any combination of two or more types of nucleotides selected from the group consisting of dATP, dGTP, dCTP, dTTP and dUTP.

38. The method of any one of claims 1-31, wherein the conducting one or more sequencing reactions comprises conducting one or more cycles of a two-stage sequencing reaction, wherein (i) the first stage comprises sequencing with a first plurality of sequencing polymerases and a plurality of detectably labeled multivalent molecules, and (ii) the second stage comprises sequencing with a second plurality of sequencing polymerases and a plurality of unlabeled nucleotide analogs.

39. The method of claim 38, wherein individual detectably labeled multivalent molecules in the plurality comprise (1) a core, (2) a plurality of nucleotide arms, and (3) at least one fluorophore, wherein individual nucleotide arms comprise (i) a core attachment moiety, (ii) a spacer comprising a PEG moiety, (iii) a linker, and (iv) a nucleotide unit, wherein the core is attached to the plurality of nucleotide arms, wherein the spacer is attached to the linker, and wherein the linker is attached to the nucleotide unit.

40. The method of claim 38, wherein the at least one single-stranded nucleic acid template molecule comprises a concatemer molecule, and wherein the first stage of the two-stage sequencing comprises forming a plurality of binding complexes, which comprises the steps: a) binding a first sequencing primer, a first sequencing polymerase, and a first multivalent molecule to a first portion of the concatemer template molecule thereby forming a first binding complex, wherein a first nucleotide unit of the first multivalent molecule binds to the first sequencing polymerase; and b) binding a second sequencing primer, a second sequencing polymerase, and the first multivalent molecule to a second portion of the same concatemer template molecule thereby forming a second binding complex, wherein a second nucleotide unit of the first multivalent molecule binds to the second sequencing polymerase, wherein the binding of steps (a) and (b) are conducted under a condition suitable to inhibit polymerase-catalyzed incorporation of the bound first and second nucleotide units in the first and second binding complexes respectively, wherein the first and second binding complexes which includes the same multivalent molecule forms an avidity complex; c) detecting the first and second binding complexes on the same concatemer template molecule; and d) identifying the first nucleotide unit in the first binding complex thereby determining the sequence of the first portion of the concatemer template molecule, and identifying the second nucleotide unit in the second binding complex thereby determining the sequence of the second portion of the concatemer template molecule.

Images